Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Gasoline Fund Lp
UGA
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
US Stock MarketDetailed Quotes
Lyra Therapeutics (LYRA)
- 0.6600
- 0.00000.00%
15min DelayClose Apr 16 14:44 ET
1.17MMarket Cap-0.04P/E (TTM)
0.6600High0.6600Low5.60KVolume0.6600Open0.6600Prev Close3.69KTurnover0.37%Turnover RatioLossP/E (Static)1.77MShares37.500052wk High-0.11P/B995.77KFloat Cap0.310052wk Low--Dividend TTM1.51MShs Float1100.0000Historical High--Div Yield TTM0.00%Range %0.3100Historical Low0.6600Avg Price1Lot Size
Lyra Therapeutics (LYRA) Key Financial Indicators
LYRA Earnings per Share (EPS)
According to the latest financial report of Lyra Therapeutics, the latest earnings per share (TTM) for the company is -3.77. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
LYRA Free Cash Flow (FCF)
Interested in knowing about Lyra Therapeutics's free cash flow? The latest report shows it as -6.16M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
LYRA Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Lyra Therapeutics shows that the company's current ratio is 1.71, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
LYRA Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Lyra Therapeutics, the quick ratio is 1.67, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
LYRA Return on Equity (ROE)
Want to learn more about the financial health of Lyra Therapeutics? The latest ROE figure is -270.73%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
LYRA Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Lyra Therapeutics, the total asset return on investment (ROA) is -17.42%.
Currency: USD
Quarterly
Loading...
LYRA Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Lyra Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
LYRA Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Lyra Therapeutics, the net profit margin is -99.30K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Trump stated on the 15th that the US-Iran war is 'about to end,' with an agreement expected to be reached before the end of April. However,
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm